Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer.
CONCLUSIONS: Combined treatment of bevacizumab and 5-fluorouracil can reduce the serum VEGF level of patients with metastatic colon cancer and prolong their PFS and OS.
PMID: 31127996 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Study